Compounded tirzepatide
Alan Meds
Alan Meds advertises $325 a month for compounded tirzepatide. We have not been able to confirm what the card is actually charged.
Price checked . How we check →
On this page
The provider price index shows published quotes separately when the charge or billing interval is missing. Ask Alan Meds for both before using the quote to budget for a month. Among the sellers we work with, the Belle Health review and the YourEra review cover the sellers nearest in recorded price; we may earn a commission from those sellers.
What it bills, and what that is per month
The $325 above is the seller's own monthly figure. It does not say how often the card is actually charged, so we cannot restate it over a calendar month or check it against a checkout.
Where it says it operates
Listed in 46 states, all but 5 of the 51 we track.
State pages this seller appears on: AL AZ AR CA CO CT DE FL GA ID IL IN IA KS KY ME MD MA MI MN MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY
What else this seller sells
The same seller appears in our data for one other medication.
- semaglutide — $158 a monththe seller’s own figure
Advertised figures have not been converted to a calendar month. These medications are priced separately from compounded tirzepatide. How the two molecules compare at every seller that sells both: compounded tirzepatide vs compounded semaglutide.
FDA has written to this seller
In , FDA sent warning letter 721814 to Alan Health Technologies Inc. dba Alan. The letter’s subject:
False & Misleading Claims/Misbranded (Telehealth)
Read the letter on fda.gov · The letter names alanmeds.com — the same site this page links to.
This seller stays in the index, at its real price. A warning letter is something you should see and weigh for yourself — an index that quietly dropped the worst records would be least useful exactly when it matters most. How we screen for these →